The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Mild ovarian stimulation for IVF
Abstract
BACKGROUND: Mild ovarian stimulation for in vitro fertilization (IVF) aims to achieve cost-effective, patient-friendly regimens which optimize the balance between outcomes and risks of treatment. METHODS: Pubmed and Medline were searched up to end of January 2008 for papers on ovarian stimulation protocols for IVF. Additionally, references to related studies were selected wherever possible. RESULTS: Studies show that mild interference with the decrease in follicle-stimulating hormone levels in the mid-follicular phase was sufficient to override the selection of a single dominant follicle. Gonadotrophin-releasing hormone antagonists compared with agonists reduce length and dosage of gonadotrophin treatment without a significant reduction in the probability of live birth (OR 0.86, 95% CI 0.72-1.02). Mild ovarian stimulation may be achieved with limited gonadotrophins or with alternatives such as anti-estrogens or aromatase inhibitors. Another option is luteinizing hormone or human chorionic gonadotrophin administration during the late follicular phase. Studies regarding these approaches are discussed individually; small sample size of single studies along with heterogeneity in patient inclusion criteria as well as outcomes analysed does not allow a meta-analysis to be performed. Additionally, the implications of mild ovarian stimulation for embryo quality, endometrial receptivity, cost and the psychological impact of IVF treatment are discussed. CONCLUSIONS: Evidence in favour of mild ovarian stimulation for IVF is accumulating in recent literature. However, further, sufficiently powered prospective studies applying novel mild treatment regimens are required and structured reporting of the incidence and severity of complications, the number of treatment days, medication used, cost, patient discomfort and number of patient drop-outs in studies on IVF is encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial and cyclic recruitment of ovarian follicles
McGee, E. A., & Hsueh, A. J. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0394 · Cited by 1,771
Mitwally, M. F. M., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01705-2 · Cited by 800 · cited 1×
“However, compared with CC they offer the potential advantage of not causing depletion of estrogen receptors (Mitwally and Casper 2001, 2003) and are more rapidly cleared from the body because of their shorter half-life (45 h instead of a few weeks).”
BackgroundAndrogens stimulate early stages of follicular growth in the primate ovary
Vendola, K. A., Zhou, J., Adesanya, O. O., Weil, S. J., & Bondy, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2081 · Cited by 712
Goswami, S. K. (2004) · Human Reproduction · doi:10.1093/humrep/deh359 · Cited by 372
Mitwally, M. F. M. (2003) · Human Reproduction · doi:10.1093/humrep/deg311 · Cited by 344
Psychological evaluation and support in a program of in vitro fertilization and embryo transfer
Freeman, E. W., Boxer, A. S., Rickels, K., Tureck, R., & Mastroianni, L. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48316-0 · Cited by 319 · cited 1×
“The stress of infertility treatment has been ranked second to that involving the death of a family member or divorce by couples undergoing IVF treatment (Freeman et al., 1985; Baram et al., 1988).”
BackgroundSuperovulation of female mice delays embryonic and fetal development
Van der Auwera, I. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1237 · Cited by 224
The Outcome of 150 Babies Following the Treatment With Letrozole or Letrozole and Gonadotropins
Biljan, M. M., Hemmings, R., & Brassard, N. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.230 · Cited by 206 · cited 2×
“Recent data have raised concerns regarding possible teratogeneity of aromatase inhibitors (Biljan et al., 2005) and ovarian stimulation is currently an off-label use again marketer's advice.”
Background
Cited by
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
Broer, S. L., Dolleman, M., Opmeer, B. C., Fauser, B. C., Mol, B. W., & Broekmans, F. J. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq034 · Cited by 485
Self-citationContemporary genetic technologies and female reproduction
The Evian Annual Reproduction (EVAR) Workshop Group 2010, Fauser, B. C. J. M., Diedrich, K., Bouchard, P., Dominguez, F., Matzuk, M., Franks, S., Hamamah, S., Simon, C., Devroey, P., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr033 · Cited by 349
Self-citationDeclining birth rate in Developed Countries: A radical policy re-think is required.
(2009) · PubMed Central · Cited by 112
(2011) · Europe PMC (PubMed Central) · Cited by 107
Metadata
- Authors
- Verberg, M. F. G., Macklon, N. S., Nargund, G., Frydman, R., Devroey, P., Broekmans, F. J., & Fauser, B. C. J. M.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-22
- Volume
- 15
- Issue
- 1
- Pages
- 13-29
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2142566171
- Cited by
- 195
- References
- 8
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.